Octreotide alleviates obesity by reducing intestinal glucose absorption and inhibiting low-grade inflammation

European Journal of Nutrition

Volumn 52, Issue 3, 2013, Pages 1067-1075

  Liu, R ^a   Wei, N ^a   Guo, W ^a   Qiang, O ^a   Li, X ^a   Ou, Y ^a   Huang, W ^a   Tang, C W ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Jejunal absorption; Maltase; Na+ dependent glucose transporter protein (SGLT 1); Obesity; Octreotide; Rat

Indexed keywords

ALPHA GLUCOSIDASE; DISACCHARIDASE; GLUCOSE; OCTREOTIDE; SODIUM GLUCOSE COTRANSPORTER 1; SOMATOSTATIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENERGY BALANCE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE ABSORPTION; IMMUNOHISTOCHEMISTRY; INTESTINE ABSORPTION; MALE; NONHUMAN; OBESITY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-OBESITY AGENTS; DIGESTION; GASTROINTESTINAL AGENTS; GENE EXPRESSION REGULATION; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; JEJUNUM; MALE; MICROVILLI; OBESITY; OCTREOTIDE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SODIUM-GLUCOSE TRANSPORTER 1; SOMATOSTATIN; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS;

RATTUS;

EID: 84879554777     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-012-0413-6     Document Type: Article

References (35)

1. Van der Merwe MT (2009) Obesity in women-a life cycle of medical risk. JEMDSA 14:139-142
2. Livhits M, Mercado C, Yermilov I, Parikh JA, Dutson E, Mehran A, Ko CY, Gibbons MM (2010) Behavioral factors associated with successful weight loss after gastric bypass. Am Surg 76:1139-1142
3. Atkinson RL (2005) Management of obesity: pharmacotherapy. In: Kopelman PG, Caterson LD, Dietz WH (eds) Clinical obesity in adults and children. Blackwell, Malden, pp 380-393
4. Cordido F, Isidro ML (2010) Approved and off-label uses of obesity medications and potential new pharmacologic treatment options. Pharmaceuticals 3:125-145
5. Lustig RH, Hinds PS, Ringwald-Smith K, Christensen RK, Kaste SC, Schreiber RE, Rai SN, Lensing SY, Wu S, Xiong X (2003) Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrinol Metab 88:2586-2592
6. Caesar R, Fåk F, Bäckhed F (2010) Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism. J Intern Med 268:320-328
7. Muccioli GG, Naslain D, Bäckhed F, Reigstad CS, Lambert DM, Delzenne NM, Cani PD (2010) The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol 6:392
8. Brignardello J, Morales P, Diaz E, Romero J, Brunser O, Gotteland M (2010) Pilot study: alterations of intestinal microbiota in obese humans are not associated with colonic inflammation or disturbances of barrier function. Aliment Pharmacol Ther 32:1307-1314
9. Mansford KRL (1967) Recent studies on carbohydrates absorption. Proc Nutr Soc 26:27-34.doi: 10.1079/PNS19670008
10. Dyer J, Daly K, Salmon KS, Arora DK, Kokrashvili Z, Margolskee RF, Shirazi-Beechey SP (2007) Intestinal glucose sensing and regulation of intestinal glucose absorption. Biochem Soc Trans 35:1191-1194
11. Ahlman H, Nilsson O (2001) The gut as the largest endocrine organ in the body. Ann Oncol 12(Suppl 2):S63-S68
12. Tang C, Lan C, Wang CH, Liu R (2005) Alleviation of multiple organ dysfunction syndrome by somatostatin via suppression of intestinal mucosal mast cells. Shock 23:470-475
13. Wu H, Liu L, Tan QH, Wang CH, Guo MM, Xie YM, Tang CW (2009) Somatostatin limits intestinal ischemia-reperfusion injury in macaques via suppression of TLR4-NF-κB cytokine pathway. J Gastrointestinal Surg 13:983-993
14. Pintér E, Helyes Z, Szolcsányi J (2006) Inhibitory effect of somatostatin on inflammation and nociception. Pharmacol Ther 112:440-456
15. Csaba Z, Dournaud P (2001) Cellular biology of somatostatin receptors. Neuropeptides 35:1-23
16. Guo MM, Tan QH, Fan H, Huang MH, Wang CH, Qiu XQ, Tang CW (2005) Changes of somatostatin and expression of somatostatin receptor in small intestine and liver tissues during macaque development. Acta Physiol Sin 57:719-724
17. Hodin RA, Saldinger P, Meng S (1995) Small bowel adaptation: counter regulatory effects of epidermal growth factor and somatostatin on the program of early gene expression. Surgery 118:206-210; discussion 210-211
18. Wang ZX, Chen JW, Zhou YK (2002) An experimental study of the effects of octreotide on small intestinal mucosa in rats. J Math Med 15:125-127 (article in Chinese)
19. Silva AP, Bethmann K, Raulf F, Schmid HA (2005) Regulation of ghrelin secretion by somatostatin analogs in rats. Eur J Endocrinol 152:887-894
20. Kang L, Routh VH, Kuzhikandathil EV, Kuzhikandathil EV, Gaspers LD, Levin BE (2004) Physiological and molecular characteristics of rat hypothalamic ventromedial nucleus glucosensing neurons. Diabetes 53:549-559
21. Hotamisligil GS, Erbay E (2008) Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol 8:923-934
22. Shoelson SE, Goldfine AB (2009) Getting away from glucose: fanning the flames of obesity-induced inflammation. Nat Med 15:373-374
23. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G (2001) Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280:E745-E751
24. Syrenicz A, Garanty-Bogacka B, Syrenicz M, Gebala A, Walczak M (2006) Low grade systemic inflammation and the risk of type 2 diabetes in obese children and adolescents. Neuro Endocrinol Lett 27:453-458
25. Panagiotakos DB, Pitsavos C, Yannakoulia M, Chrysohoou C, Stefanadis C (2005) The implication of obesity and central fat on markers of chronic inflammation: the ATTICA study. Atherosclerosis 183:308-315
26. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB (2001) Low grade systemic inflammation in overweight children. Pediatrics 107:E13
27. Dandona P, Weinstock R, Thusu K, Abdel-Rahman E, Aljada A (1998) Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab 83:2907-2910
28. Lee YH, Pratley RE (2005) The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep 5:70-75
29. Zhou C, Li J, Wang HY, Tang CW (2009) Decreased somatostatin is related to the hypersensitivity of intestinal epithelia to LPS via up-regulated TLR4-TBK1 pathway in rats chronically exposed to ethanol. Alcohol 43:293-303
30. Joshi MS, Crouser ED, Julian MW, Schanbacher BL, Bauer JA (2000) Digital imaging analysis for the study of endotoxin-induced mitochondrial ultrastructure injury. Anal Cell Pathol 21:41-48
31. Rosensweig NS (1975) Diet and intestinal enzyme adaptation: implications for gastrointestinal disorders. Am J Clin Nutr 28:648-655
32. Ferraris RP, Villenas SA, Diamond J (1992) Regulation of brush-border enzyme activities and enterocyte migration rates in mouse small intestine. Am J Physiol Gastrointest Liver Physiol 262:G1047-G1059
33. Black BL, Croom J, Eisen EJ, Petro AE, Edwards CL, Surwit RS (1998) Differential effects of fat and sucrose on body composition in A/J and C57BL/6 mice. Metabolism 47:1354-1359
34. Hediger MA, Rhoads DB (1994) Molecular physiology of sodium glucose cotransporters. Physiol Rev 74:993-1026
35. Lee JY, Hannun YA, Obeid LM (2000) Functional dichotomy of protein kinase C (PKC) in tumor necrosis factor-a (TNF-α) signal transduction in L929 cells. J Biol Chem 275:29290-29298